Literature DB >> 8857939

Epidemiological studies of spectrin mutations related to hereditary elliptocytosis and spectrin polymorphisms in Benin.

C Glele-Kakai1, M Garbarz, M C Lecomte, S Leborgne, C Galand, O Bournier, I Devaux, H Gautero, I Zohoun, P G Gallagher, B G Forget, D Dhermy.   

Abstract

We studied an African population in Benin and discovered an unexpectedly high frequency (1.6%) of hereditary elliptocytosis (HE) among the 1447 subjects studied. In approximately two-thirds of HE individuals we identified molecular defects, primarily those in erythrocyte alpha-spectrin (dupL154, L260P and L207P mutations), as well as a novel mutation of erythrocyte beta-spectrin (beta-W2061R mutation). We also identified the genetic basis of a previously identified protein polymorphism of the alpha III domain of spectrin (R1331I mutation). The genetic background of HE in the African population was studied using a number of polymorphisms of the alpha-spectrin gene, including the alpha III domain polymorphism. These studies suggest that the HE mutations appear to have originated from separate genetic backgrounds in this population.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8857939     DOI: 10.1046/j.1365-2141.1996.d01-1869.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  15 in total

Review 1.  The spectrin-ankyrin-4.1-adducin membrane skeleton: adapting eukaryotic cells to the demands of animal life.

Authors:  Anthony J Baines
Journal:  Protoplasma       Date:  2010-07-29       Impact factor: 3.356

Review 2.  Abnormalities of the erythrocyte membrane.

Authors:  Patrick G Gallagher
Journal:  Pediatr Clin North Am       Date:  2013-10-15       Impact factor: 3.278

Review 3.  Probing structures of large protein complexes using zero-length cross-linking.

Authors:  Roland F Rivera-Santiago; Sira Sriswasdi; Sandra L Harper; David W Speicher
Journal:  Methods       Date:  2015-05-01       Impact factor: 3.608

4.  Spectrin self-association site: characterization and study of beta-spectrin mutations associated with hereditary elliptocytosis.

Authors:  G Nicolas; S Pedroni; C Fournier; H Gautero; C Craescu; D Dhermy; M C Lecomte
Journal:  Biochem J       Date:  1998-05-15       Impact factor: 3.857

5.  Erythrocyte β spectrin can be genetically targeted to protect mice from malaria.

Authors:  Patrick M Lelliott; Hong Ming Huang; Matthew W Dixon; Arman Namvar; Adam J Blanch; Vijay Rajagopal; Leann Tilley; Cevayir Coban; Brendan J McMorran; Simon J Foote; Gaetan Burgio
Journal:  Blood Adv       Date:  2017-12-12

Review 6.  The role of the red blood cell in host defence against falciparum malaria: an expanding repertoire of evolutionary alterations.

Authors:  Morgan M Goheen; Susana Campino; Carla Cerami
Journal:  Br J Haematol       Date:  2017-08-23       Impact factor: 6.998

7.  Structural and functional effects of hereditary hemolytic anemia-associated point mutations in the alpha spectrin tetramer site.

Authors:  Massimiliano Gaetani; Sara Mootien; Sandra Harper; Patrick G Gallagher; David W Speicher
Journal:  Blood       Date:  2008-01-24       Impact factor: 22.113

8.  The common hereditary elliptocytosis-associated α-spectrin L260P mutation perturbs erythrocyte membranes by stabilizing spectrin in the closed dimer conformation.

Authors:  Sandra L Harper; Sira Sriswasdi; Hsin-Yao Tang; Massimiliano Gaetani; Patrick G Gallagher; David W Speicher
Journal:  Blood       Date:  2013-08-23       Impact factor: 22.113

9.  Clinical and molecular genetic analysis of a Chinese family with hereditary elliptocytosis caused by a novel mutation in the EPB41 gene.

Authors:  Manxiong Cao; Zhanqin Huang; Huanbing Zhou; Jinghua Lin; Dongqing Zhang
Journal:  J Clin Lab Anal       Date:  2021-05-04       Impact factor: 2.352

10.  Hereditary elliptocytosis-associated alpha-spectrin mutation p.L155dup as a modifier of sickle cell disease severity.

Authors:  Mary Risinger; Georgios E Christakopoulos; Corinna L Schultz; Patrick T McGann; Wenying Zhang; Theodosia A Kalfa
Journal:  Pediatr Blood Cancer       Date:  2018-11-04       Impact factor: 3.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.